SCHEMBL10176169

SCHEMBL10176169

CN(c1ccc(Cl)cc1)c1ccc(C(=N)c2cc(Oc3ccccc3)cc(C(=O)O)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.43
AKR1C3 P42330 1/20 0.43
STAT3 P40763 1/20 0.42
LTC4S Q16873 5/20 0.41
UTS2R Q9UKP6 1/20 0.40
SERPINE1 P05121 1/20 0.40
SRD5A2 P31213 1/20 0.40
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NR4A2 P43354 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
SCN9A Q15858 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233238 0.88 SRD5A2 (0.51) PGRAKR1C3STAT3LTC4SUTS2R
SCHEMBL230335 0.84 ALDH1A1 (0.43) PGRAKR1C3STAT3LTC4SUTS2R
SCHEMBL10177392 0.84 PGR (0.41) PGRAKR1C3STAT3LTC4SUTS2R
SCHEMBL230334 0.84 ALDH1A1 (0.43) PGRAKR1C3STAT3LTC4SUTS2R
SCHEMBL2743161 0.83 LMNA (0.48) LTC4SSRD5A2LMNAL3MBTL1SCN9A
SCHEMBL231165 0.82 STAT3 (0.40) PGRAKR1C3STAT3LTC4SUTS2R
SCHEMBL231166 0.82 STAT3 (0.40) PGRAKR1C3STAT3LTC4SUTS2R
SCHEMBL2743160 0.81 MRGPRX4 (0.45) PGRAKR1C3LTC4SSRD5A2LMNA
SCHEMBL233091 0.79 LTC4S (0.59) LTC4S
SCHEMBL2743156 0.79 LTC4S (0.49) LTC4SLMNAL3MBTL1MRGPRX4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R PGR 2395/4885AKR1C3 77/4885STAT3 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.